未经治疗主动脉瓣狭窄的死亡负担
基于美国24家医院1,085,850例患者的超声报告,分析未经治疗主动脉瓣狭窄(AS)各严重程度的4年全因死亡率。结果显示死亡率随AS严重程度递增,重度AS达44.9%,但重度AS的4年治疗率仅60.7%,提示治疗率偏低。
要点
- 未经治疗AS的4年死亡率随严重程度递增,重度达44.9%。
- 重度AS的4年主动脉瓣置换率仅60.7%,治疗不足。
- 即使轻度AS也与死亡率增加相关,需重视早期识别。
核心结论
- 未经治疗的AS在所有严重程度下均存在高死亡风险。
- 重度AS患者的主动脉瓣置换率仍较低,需研究诊断和治疗障碍。
研究设计与样本
- 分析美国24家医院1,669,536份超声报告(1,085,850例患者)的真实世界数据。
- 18岁以上患者按诊断的AS严重程度分类,采用Kaplan-Meier估计未治疗死亡率和治疗率。
主要发现
- 在595,120例有AS严重程度评估的患者中,4年未调整未治疗全因死亡率:无AS为13.5%(95%CI 13.3%-13.7%),轻度为25.0%(95%CI 23.8%-26.1%),轻-中度为29.7%(95%CI 26.8%-32.5%),中度为33.5%(95%CI 31.0%-35.8%),中-重度为45.7%(95%CI 37.4%-52.8%),重度为44.9%(95%CI 39.9%-49.6%)。
- 4年观察治疗率:无AS为0.2%(95%CI 0.2%-0.2%),轻度为1.0%(95%CI 0.7%-1.3%),轻-中度为4.2%(95%CI 2.0%-6.3%),中度为11.4%(95%CI 9.5%-13.3%),中-重度为36.7%(95%CI 31.8%-41.2%),重度为60.7%(95%CI 58.0%-63.3%)。
- 调整后,所有AS严重程度均与死亡率增加相关。
关键数值与推荐
- 美国心脏病学会/美国心脏协会指南推荐按超声评估AS严重程度(轻度、中度、重度),重度AS推荐主动脉瓣置换。
临床怎么用
- 临床中应重视AS的严重程度评估,并关注重度AS患者的治疗可及性。
- 对于重度AS,需评估主动脉瓣置换的时机和障碍,以提高治疗率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The American College of Cardiology/American Heart Association guidelines recommend the assessment and grading of severity of aortic stenosis (AS) as mild, moderate, or severe, per echocardiogram, and recommend aortic valve replacement (AVR) when the AS is severe. OBJECTIVES: The authors sought to describe mortality rates across the entire spectrum of untreated AS from a contemporary, large, real-world database. METHODS: We analyzed a deidentified real-world data set including 1,669,536 echocardiographic reports (1,085,850 patients) from 24 U.S. hospitals (egnite Database, egnite). Patients >18 years of age were classified by diagnosed AS severity. Untreated mortality and treatment rates were examined with Kaplan-Meier (KM) estimates, with results compared using the log-rank test. Multivariate hazards analysis was performed to assess associations with all-cause mortality. RESULTS: Among 595,120 patients with available AS severity assessment, the KM-estimated 4-year unadjusted, untreated, all-cause mortality associated with AS diagnosis of none, mild, mild-to-moderate, moderate, moderate-to-severe, or severe was 13.5% (95% CI: 13.3%-13.7%), 25.0% (95% CI: 23.8%-26.1%), 29.7% (95% CI: 26.8%-32.5%), 33.5% (95% CI: 31.0%-35.8%), 45.7% (95% CI: 37.4%-52.8%), and 44.9% (95% CI: 39.9%-49.6%), respectively. Results were similar when adjusted for informative censoring caused by treatment. KM-estimated 4-year observed treatment rates were 0.2% (95% CI: 0.2%-0.2%), 1.0% (95% CI: 0.7%-1.3%), 4.2% (95% CI: 2.0%-6.3%), 11.4% (95% CI: 9.5%-13.3%), 36.7% (95% CI: 31.8%-41.2%), and 60.7% (95% CI: 58.0%-63.3%), respectively. After adjustment, all degrees of AS severity were associated with increased mortality. CONCLUSIONS: Patients with AS have high mortality risk across all levels of untreated AS severity. Aortic valve replacement rates remain low for patients with severe AS, suggesting that more research is needed to understand barriers to diagnosis and appropriate approach and timing for aortic valve replacement.
引用
- Généreux P, Sharma RP, Cubeddu RJ, et al. The Mortality Burden of Untreated Aortic Stenosis. J Am Coll Cardiol. 2023. PMID: 37877909. doi:10.1016/j.jacc.2023.09.796
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。